Skip to main content

Find Clinical Trials

Home
Conditions
Skin Basal Cell Carcinoma

Clinical trial condition

Skin Basal Cell Carcinoma

Explore clinical trials studying Skin Basal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Skin Basal Cell Carcinoma trial results

Completed

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

NCT02579551

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
Locations: Thomas Jefferson Univeristy Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

NCT03180528

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Topical Itraconazole in Treating Patients With Basal Cell Cancer

NCT02735356

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

View Trial Details

Completed

Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

NCT02690948

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
Locations: Stanford University School of Medicine Palo Alto, California, United States

View Trial Details

Active, Not Recruiting

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

NCT07144384

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +6 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

NCT06539468

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Active, Not Recruiting

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

NCT02978625

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

Keck Medical Center of USC Pasadena Pasadena, California, United States

View all 36 locations

View Trial Details